INXMED

inxmed-logo

InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equipped with global-level top-notch know-how and efficient execution capabilities.

#SimilarOrganizations #People #Financial #Website #More

INXMED

Social Links:

Industry:
Biotechnology Life Science

Founded:
2018-01-01

Address:
Shanghai, Shanghai, China

Country:
China

Website Url:
http://www.en.inxmed.com

Total Employee:
11+

Status:
Active

Contact:
+0086-21-50630108

Email Addresses:
[email protected]

Total Funding:
94 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Mobile Non Scaleable Content Euro Microsoft Exchange Online Office 365 Mail IPv6 Pound Sterling


Similar Organizations

alebund-pharmaceuticals-logo

Alebund Pharmaceuticals

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

alphamab-oncology-logo

Alphamab Oncology

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

antengene-corporation-logo

Antengene Corporation

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

aum-biosciences-logo

AUM Biosciences

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

inventisbio-logo

InventisBio

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

nectin-therapeutics-logo

Nectin Therapeutics

Nectin Therapeutics is a startup company dedicated to the development of next generation immuno-oncology antibodies.

oncohost-logo

OncoHost

OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.

visen-pharmaceuticals-logo

Visen Pharmaceuticals

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.


Current Advisors List

michael-keyoung_image

Michael Keyoung Board Member @ InxMed
Board_member
2020-03-01

Current Employees Featured

not_available_image

James Mc Leod
James Mc Leod EVP & US Chief Medical Officer @ InxMed
EVP & US Chief Medical Officer
2019-02-01

francis-cao_image

Francis Cao
Francis Cao Co-Founder & COO @ InxMed
Co-Founder & COO
2017-10-01

not_available_image

Zaiqi Wang
Zaiqi Wang Chief Executive Officer & Chairman & Founder @ InxMed
Chief Executive Officer & Chairman & Founder

Founder


francis-cao_image

Francis Cao

not_available_image

Zaiqi Wang

Investors List

spd-silicon-valley-bank-ssvb_image

SPD Silicon Valley Bank (SSVB)

SPD Silicon Valley Bank (SSVB) investment in Debt Financing - InxMed

hyfinity-investments_image

Hyfinity Investments

Hyfinity Investments investment in Series B - InxMed

ennovation-ventures_image

Ennovation Ventures

Ennovation Ventures investment in Series B - InxMed

aihc-capital_image

AIHC Capital

AIHC Capital investment in Series B - InxMed

cs-capital_image

CS Capital

CS Capital investment in Series B - InxMed

hosencare-brothers_image

HosenCare Brothers

HosenCare Brothers investment in Series B - InxMed

ennovation-ventures_image

Ennovation Ventures

Ennovation Ventures investment in Series A - InxMed

china-growth-capital_image

China Growth Capital | CGC

China Growth Capital | CGC investment in Series A - InxMed

innomed-capital_image

InnoMed Capital

InnoMed Capital investment in Series A - InxMed

grand-yangtze-capital_image

Grand Yangtze Capital

Grand Yangtze Capital investment in Series A - InxMed

Official Site Inspections

http://www.en.inxmed.com

  • Host name: server-99-84-188-57.iad89.r.cloudfront.net
  • IP address: 99.84.188.57
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "InxMed" on Search Engine